论文
58
AI 评分(两次独立评分的平均)OpenAI 介绍 GPT-Rosalind 如何辅助发现神经退行性疾病新线索
原标题:How AI is helping scientists uncover new leads for understanding and treating neurodegenerative diseases—and the brain research behind ou...
OpenAI 介绍 AI 如何帮助科学家发现理解和治疗神经退行性疾病的新线索,并说明其与 PerturbAI、Scripps Research 合作背后的脑研究。引用内容显示,GPT-Rosalind 针对与 Perry 综合征相关的 DCTN1 基因提出解释:胆固醇可能未到达神经元所需位置,从而给出可检验的机制方向。数千个 GPT-Rosalind 智能体并行工作,在 32 分钟内将数百万小鼠脑细胞的基因表达结果与科学文献关联起来,双方正扩大合作以寻找新药物靶点。
中文译文尚未完成,先为你展示原文。
How AI is helping scientists uncover new leads for understanding and treating neurodegenerative diseases—and the brain research behind our collaboration with @perturbai_tx and @scrippsresearch:
GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration? DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in making cholesterol. GPT-Rosalind suggested a possible explanation: cholesterol may not be reaching where neurons need it. That gives scientists a specific mechanism to test and, if confirmed, a direction for developing new treatments for neurodegenerative disorders. With @perturbai_tx and @scrippsresearch, a team of thousands of GPT-Rosalind agents worked in parallel, connecting gene-expression results from millions of mouse brain cells with scientific literature in just 32 minutes. We’re now expanding this collaboration to identify new drug targets. https://openai.com/index/scaling-ai-research-for-complex-biological-data/查看原帖
同一件事的其他报道1 篇
Greg Brockman · 原文
